Shay Soker to Vascular Endothelial Growth Factors
This is a "connection" page, showing publications Shay Soker has written about Vascular Endothelial Growth Factors.
Connection Strength
0.220
-
Schuch G, Machluf M, Bartsch G, Nomi M, Richard H, Atala A, Soker S. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood. 2002 Dec 15; 100(13):4622-8.
Score: 0.057
-
Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002 Dec; 23(6):463-83.
Score: 0.057
-
Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem. 2002; 85(2):357-68.
Score: 0.053
-
Schuch G, Kisker O, Atala A, Soker S. Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. Angiogenesis. 2002; 5(3):181-90.
Score: 0.053